Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
20.86
+0.56 (2.76%)
Nov 25, 2025, 4:00 PM EST - Market closed

Roivant Sciences Revenue

Roivant Sciences had revenue of $1.57M in the quarter ending September 30, 2025, a decrease of -64.89%. This brings the company's revenue in the last twelve months to $20.33M, down -45.13% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$20.33M
Revenue Growth
-45.13%
P/S Ratio
713.66
Revenue / Employee
$27,105
Employees
750
Market Cap
14.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

ROIV News

More News